1. Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer
    Jong Lyul Lee et al, 2019, World Journal of Gastroenterology CrossRef
  2. The Multifaceted Roles of Copper in Cancer: A Trace Metal Element with Dysregulated Metabolism, but Also a Target or a Bullet for Therapy
    Pierre Lelièvre et al, 2020, Cancers CrossRef
  3. LOXL4 knockdown enhances tumor growth and lung metastasis through collagen-dependent extracellular matrix changes in triple-negative breast cancer
    Sul Ki Choi et al, 2017, Oncotarget CrossRef
  4. Interplay Between LOX Enzymes and Integrins in the Tumor Microenvironment
    Pier Giorgio Amendola et al, 2019, Cancers CrossRef
  5. Nuclear expression of lysyl oxidase enzyme is an independent prognostic factor in rectal cancer patients
    Na Liu et al, 2017, Oncotarget CrossRef
  6. Lysyl oxidases: Emerging biomarkers and therapeutic targets for various diseases
    Nan Yang et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  7. Lysyl oxidase family members in urological tumorigenesis and fibrosis
    Tao Li et al, 2018, Oncotarget CrossRef
  8. LOXL2 in epithelial cell plasticity and tumor progression
    Amparo Cano et al, 2012, Future Oncology CrossRef
  9. Herbal compound Teng‑Long‑Bu‑Zhong‑Tang inhibits metastasis in human RKO colon carcinoma
    Meng‑Meng Wei et al, 2017, Oncology Letters CrossRef
  10. Lysyl oxidase in colorectal cancer
    Thomas R. Cox et al, 2013, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
  11. The Role of Lysyl Oxidase in SRC-Dependent Proliferation and Metastasis of Colorectal Cancer
    Ann-Marie Baker et al, 2011, JNCI: Journal of the National Cancer Institute CrossRef
  12. Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
    Carmen Chak-Lui Wong et al, 2011, Proceedings of the National Academy of Sciences CrossRef
  13. The apparent competitive action of ECM proteases and cross-linking enzymes during fibrosis: Applications to drug discovery
    Nikolaos A. Afratis et al, 2018, Advanced Drug Delivery Reviews CrossRef
  14. Downregulation of lysyl oxidase‐like 4 LOXL4 by miR‐135a‐5p promotes lung cancer progression in vitro and in vivo
    Ying Zhang et al, 2019, Journal of Cellular Physiology CrossRef
  15. Lysyl oxidase: A colorectal cancer biomarker of lung and hepatic metastasis
    Yun Liu et al, 2018, Thoracic Cancer CrossRef
  16. Cancer as a biophysical disease: Targeting the mechanical-adaptability program
    Ly T.S. Nguyen et al, 2022, Biophysical Journal CrossRef
  17. LOXL2 in cancer: regulation, downstream effectors and novel roles
    Bing Wen et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  18. Tumor Cell Invasion Can Be Blocked by Modulators of Collagen Fibril Alignment That Control Assembly of the Extracellular Matrix
    Moran Grossman et al, 2016, Cancer Research CrossRef
  19. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma
    Shitong Lin et al, 2020, Cancer Medicine CrossRef
  20. Pan-Cancer Analysis of the LOX Family Reveals that LOX Affects Tumor Prognosis by Affecting Immune Infiltration
    Chunlong Zheng et al, 2024, Critical Reviews in Eukaryotic Gene Expression CrossRef
  21. Matrix Stiffness and Colorectal Cancer


    Chongshun Liu et al, 2020, OncoTargets and Therapy CrossRef
  22. The HIF-1–Inducible Lysyl Oxidase Activates HIF-1 via the Akt Pathway in a Positive Regulation Loop and Synergizes with HIF-1 in Promoting Tumor Cell Growth
    Floriane Pez et al, 2011, Cancer Research CrossRef